Press Releases

Sep 7, 2023

Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Aug 8, 2023

Syros Reports Second Quarter 2023 Financial Results and Provides a Corporate Update

Aug 4, 2023

Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Aug 1, 2023

Syros to Report Second Quarter 2023 Financial Results on Tuesday, August 8, 2023

Jul 5, 2023

Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Jun 8, 2023

Syros to Present at Sidoti June 2023 Virtual Small-Cap Conference

Jun 1, 2023

Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 25, 2023

Syros Presents Data from Phase 1/1b Clinical Trial of SY-5609 in Advanced Solid Tumors at ASCO Annual Meeting

May 10, 2023

Syros Reports First Quarter 2023 Financial Results and Provides a Corporate Update

May 9, 2023

Syros to Present at JMP Securities 2023 Life Sciences Conference